IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,531,044 | -40.5% | 239,600 | +77.6% | 0.22% | +317.0% |
| Q4 2021 | $2,575,000 | -53.8% | 134,900 | -40.3% | 0.05% | -68.6% |
| Q3 2021 | $5,574,000 | +167.7% | 226,000 | +182.5% | 0.17% | +128.4% |
| Q2 2021 | $2,082,000 | +31.5% | 80,000 | +60.0% | 0.07% | +85.0% |
| Q1 2021 | $1,583,000 | -86.5% | 50,000 | -80.2% | 0.04% | -82.1% |
| Q4 2020 | $11,739,000 | +17.7% | 253,000 | -16.5% | 0.22% | -39.6% |
| Q3 2020 | $9,975,000 | +372.5% | 303,000 | +294.0% | 0.37% | +152.7% |
| Q2 2020 | $2,111,000 | +1307.3% | 76,900 | +1438.0% | 0.15% | +630.0% |
| Q1 2020 | $150,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |